FibroBiologics, Inc.
FBLG
$0.8762
$0.00120.14%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 52.62% | -27.30% | -47.50% | 260.02% | 304.37% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 525.00% | 1,207.41% | 661.76% | -- | 24.14% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 12.50% | -85.12% | -94.27% | -- | -46.67% |
Total Current Assets | 54.40% | -24.89% | -44.65% | -- | 251.05% |
|
|||||
Total Current Assets | 54.40% | -24.89% | -44.65% | -- | 251.05% |
Net Property, Plant & Equipment | -14.93% | -4.78% | 15.31% | -- | 18.51% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 39.12% | -21.28% | -35.63% | -- | 145.05% |
|
|||||
Total Accounts Payable | 86.77% | 43.78% | 102.01% | -- | 90.50% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -18.44% | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 10.77% | 11.05% | 11.05% | -- | 11.04% |
Total Finance Division Other Current Liabilities | -93.76% | -- | -- | -- | 1,271.19% |
Total Other Current Liabilities | -93.76% | -- | -- | -- | 1,271.19% |
Total Current Liabilities | 38.58% | 408.14% | 975.58% | -- | 29.83% |
|
|||||
Total Current Liabilities | 38.58% | 408.14% | 975.58% | -- | 29.83% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -18.44% | -- | -- | -- |
Capital Leases | -28.95% | -27.09% | -24.66% | -- | -20.72% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 29.73% | 180.04% | 353.59% | -- | 19.82% |
|
|||||
Common Stock & APIC | 49.37% | 39.63% | 24.08% | -- | 960.46% |
Retained Earnings | -45.82% | -121.44% | -156.42% | -- | -209.41% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 118.28% | -74.03% | -121.03% | 3.33% | 131.36% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 118.28% | -74.03% | -121.03% | 3.33% | 131.36% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 118.28% | -74.03% | -121.03% | 3.33% | 131.36% |
|